Arch Therapeutics
(OTC) ARTH
Arch Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$148.16K
Net Income (TTM)
$12.26M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ARTH News
ARTH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Arch Therapeutics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
8
CEO
Terrence W. Norchi, MD, MBA
Website
www.archtherapeutics.comHeadquarters
Framingham, MA 01702, US
ARTH Financials
Key Financial Metrics (TTM)
Gross Margin
-3%
Operating Margin
-67%
Net Income Margin
-92%
Return on Equity
1%
Return on Capital
67%
Return on Assets
-4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$2.44K
Operating Income
$5.04M
EBITDA
$3.88M
Operating Cash Flow
$3.37M
Capital Expenditure
$4.52K
Free Cash Flow
$3.38M
Cash & ST Invst.
$222.72K
Total Debt
$5.63M
Arch Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$30.91K
+132.6%
Gross Profit
$9.83K
+287.8%
Gross Margin
31.81%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
8
N/A
Net Income
$5.65M
-210.2%
EBITDA
$4.98M
-391.3%
Quarterly Fundamentals
Net Cash
$9.36M
-211.4%
Accounts Receivable
$0.00
N/A
Inventory
$1.32M
-4.5%
Long Term Debt
$0.00
N/A
Short Term Debt
$9.39M
+54.2%
Return on Assets
-3.57%
N/A
Return on Invested Capital
67.19%
N/A
Free Cash Flow
$911.64K
-1.6%
Operating Cash Flow
$911.64K
-1.6%